The natural progression of peanut allergy: Resolution and the possibility of recurrence

被引:175
作者
Fleischer, DM
Conover-Walker, MK
Christie, L
Burks, AW
Wood, RA
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[2] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA
[3] Arkansas Childrens Hosp, Little Rock, AR 72202 USA
关键词
peanut allergy; food challenge; recurrence; RAST; food hypersensitivity;
D O I
10.1067/mai.2003.1517
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: It was once thought that peanut allergy is a lifelong problem. We previously reported that about 20% of children outgrow their peanut allergy and that more than 60% of patients with a peanut-IgE level of 5 or less passed an oral challenge. Objective: The goal of this study was to further describe the natural progression of peanut allergy by reviewing patients who have undergone oral peanut challenges since the previous study. Methods: Patients with peanut-IgE levels of 5 or less were offered a peanut challenge. Those who passed were further evaluated by questionnaire to assess reintroduction of peanut into their diet and whether any recurrence has occurred. Results: Eighty-four patients were evaluated, and 80 underwent complete analysis. Fifty-five percent with peanut-IgE levels of 5 or less and 63% with peanut-IgE levels of 2 or less passed challenges, compared to 61% and 67%, respectively, in our previous study. The 4 additional patients passed peanut challenges in this study after previously failing. Three patients with initial anaphylactic reactions and 2 patients with initial peanut-IgE levels greater than 70 passed their challenge. Follow-up of those who passed in both studies showed that the majority of patients reintroduced peanut into their diet, but that continued label reading, infrequent/limited ingestion, and aversion to peanut were all common in this population. Two patients had suspected subsequent reactions to peanut after passing their challenge. Conclusions: Patients with a history of peanut allergy and peanut-IgE levels of 5 or less have at least a 50% chance of outgrowing their allergy. Recurrence of peanut allergy may occur but appears to be uncommon.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 14 条
[1]   Fatalities due to anaphylactic reactions to foods [J].
Bock, SA ;
Muñoz-Furlong, A ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) :191-193
[2]   Recurrent peanut allergy [J].
Busse, PJ ;
Nowak-Wegrzyn, AH ;
Noone, SA ;
Sampson, HA ;
Sicherer, SH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (19) :1535-1536
[3]   Recurrence of peanut allergy [J].
Busse, PJ ;
Noone, SA ;
Nowak-Wegrzyn, AH ;
Sampson, HA ;
Sicherer, SH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) :S92-S92
[4]   Prevalence of IgE-mediated food allergy among children with atopic dermatitis [J].
Eigenmann, PA ;
Sicherer, SH ;
Borkowski, TA ;
Cohen, BA ;
Sampson, HA .
PEDIATRICS, 1998, 101 (03) :E8
[5]   Perceived prevalence of peanut allergy in Great Britain and its association with other atopic conditions and with peanut allergy in other household members [J].
Emmett, SE ;
Angus, FJ ;
Fry, JS ;
Lee, PN .
ALLERGY, 1999, 54 (04) :380-385
[6]   Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts [J].
Grundy, J ;
Matthews, S ;
Bateman, B ;
Dean, T ;
Arshad, SH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (05) :784-789
[7]  
Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518
[8]   Resolution of peanut allergy: case-control study [J].
Hourihane, JO ;
Roberts, SA ;
Warner, JO .
BRITISH MEDICAL JOURNAL, 1998, 316 (7140) :1271-1275
[9]   Population study of food allergy in France [J].
Kanny, G ;
Moneret-Vautrin, DA ;
Flabbee, J ;
Beaudouin, E ;
Morisset, M ;
Thevenin, F .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (01) :133-140
[10]   A voluntary registry for peanut and tree nut allergy:: Characteristics of the first 5149 registrants [J].
Sicherer, SH ;
Furlong, TJ ;
Muñoz-Furlong, A ;
Burks, AW ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (01) :128-132